Agilent Technologies Inc (NYSE:A) Given Consensus Recommendation of “Buy” by Analysts

Agilent Technologies Inc (NYSE:A) has earned an average recommendation of “Buy” from the sixteen ratings firms that are covering the company, Marketbeat reports. Seven investment analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $84.08.

A has been the topic of several research reports. Needham & Company LLC boosted their target price on Agilent Technologies to $92.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Barclays dropped their price target on Agilent Technologies from $78.00 to $76.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 9th. Stifel Nicolaus initiated coverage on Agilent Technologies in a research note on Thursday, November 14th. They set a “hold” rating and a $85.00 price target for the company. Robert W. Baird reissued an “outperform” rating and issued a $82.00 price objective (up previously from $79.00) on shares of Agilent Technologies in a report on Thursday, August 15th. Finally, Zacks Investment Research lowered Agilent Technologies from a “buy” rating to a “hold” rating and set a $75.00 price objective for the company. in a report on Monday, August 19th.

In other news, Director Heidi Fields sold 4,000 shares of the company’s stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $78.56, for a total transaction of $314,240.00. Following the sale, the director now directly owns 53,287 shares in the company, valued at $4,186,226.72. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Michael R. Mcmullen sold 24,635 shares of the stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $77.50, for a total transaction of $1,909,212.50. The disclosure for this sale can be found here. Insiders sold 32,635 shares of company stock valued at $2,507,293 over the last ninety days.

A number of institutional investors have recently bought and sold shares of A. Flagship Harbor Advisors LLC raised its holdings in shares of Agilent Technologies by 139.0% in the 2nd quarter. Flagship Harbor Advisors LLC now owns 349 shares of the medical research company’s stock valued at $26,000 after acquiring an additional 203 shares in the last quarter. Capital Investment Advisory Services LLC bought a new position in shares of Agilent Technologies in the second quarter worth approximately $26,000. Liberty Wealth Management LLC purchased a new stake in Agilent Technologies in the second quarter valued at approximately $29,000. WealthStone Inc. purchased a new stake in Agilent Technologies in the second quarter valued at approximately $31,000. Finally, Coastal Capital Group Inc. purchased a new stake in Agilent Technologies in the second quarter valued at approximately $32,000.

Shares of NYSE:A traded down $0.77 during mid-day trading on Friday, reaching $78.52. The company had a trading volume of 1,898,035 shares, compared to its average volume of 2,209,093. The company has a current ratio of 2.13, a quick ratio of 1.72 and a debt-to-equity ratio of 0.27. The firm has a market cap of $24.22 billion, a price-to-earnings ratio of 28.14, a PEG ratio of 1.94 and a beta of 1.42. The company’s 50-day moving average price is $75.84 and its 200-day moving average price is $72.87. Agilent Technologies has a one year low of $62.00 and a one year high of $82.27.

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were issued a $0.164 dividend. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.84%. The ex-dividend date of this dividend was Monday, September 30th. Agilent Technologies’s payout ratio is currently 23.66%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Read More: Swap

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with's FREE daily email newsletter.